JANUMET 50/1GM is a combination of sitagliptin and metformin Sitagliptin belongs to a group of medicines called DPP-4 inhibitors (dipeptidylpeptidase-4 inhibitors) Metformin belongs to a group of medicines called biguanides
14392JANUMET 50/1000 MG TAB is a powerful combination medication designed to effectively manage blood sugar levels in patients with type 2 diabetes. It combines sitagliptin, a DPP-4 inhibitor, with metformin, a biguanide, to provide a dual-action approach to diabetes management.
Key Features
Benefits
Active Ingredients and Their Benefits